2021-05-27
The opinion clearly states: prioritize support for regulatory science research in areas such as traditional Chinese medicine, biologics (including vaccines), gene therapies, cell-based therapies, AI-powered medical devices, new materials for medical devices, and novel cosmetic ingredients, thereby accelerating the development and market launch of innovative products.
+2021-05-25
CCTV: Stem cells help a cerebral palsy patient take their first steps in over 20 years.
The development of stem cell technology has become increasingly mature, demonstrating remarkable therapeutic efficacy in the diagnosis and treatment of many challenging and complex diseases, and offering new hope for patients suffering from these often-intractable conditions.
+2021-05-17
On May 12, the 84th National Pharmaceutical Fair (hereinafter referred to as "PharmFair") kicked off with great fanfare at the Shanghai National Exhibition and Convention Center. Renowned as a "Time-Honored Chinese Brand" with a rich history spanning 371 years and listed on the "Intangible Cultural Heritage Protection Catalog," Jiuzhitang Group showcased its comprehensive lineup at this year's event, featuring prescription drugs, OTC products, innovative health solutions, cutting-edge stem-cell initiatives, and its thriving internet-based healthcare platform.
+2021-04-29
[Invitation] Jiuzhitang Group cordially invites you to visit the 84th National Pharmaceutical Fair, where we’ll be showcasing at Booth 82J18 in Hall 8.2.
+2021-04-28
Does the more stem cells used, the better the treatment effect?
In fact, there are many factors that influence the effectiveness of cell therapies—so we shouldn’t focus solely on dosage, but rather pay closer attention to cell quality and whether clinical application is being carried out correctly.
+2021-04-20
The key document explicitly states: "Carry out the initial review of clinical research institutions and projects involving stem cells and somatic cells, strengthen policy advisory services and pre-application guidance, support collaborative efforts between registered institutions and companies in conducting clinical research, and provide crucial evidence-based support to accelerate the transition of stem cell therapies into clinical practice."
+2021-04-14
Moving forward, we hope to leverage the "first-mover advantage" and pioneering policies of the Lecity Pilot Zone, along with its initiatives in real-world data research, to fast-track the approval and launch of Jiuzhitang's innovative products in China. By doing so, we aim to deliver valuable health solutions and services to people worldwide, solidifying our position as the public’s top-choice health partner and ultimately contributing even greater value to global human health!
+2021-04-09
As regenerative medicine continues to advance and refine, stem cell therapy has already brought hope to countless patients suffering from previously intractable diseases. Looking ahead, stem cells are poised to make even greater strides in treating a wider range of illnesses, offering renewed optimism to more patients in the years to come.
+